ILLUMINA INC (ILU.DE) Stock Overview
Europe - FRA:ILU - US4523271090 - Common Stock
ILU.DE Key Statistics, Chart & Performance
The current stock price of ILU.DE is 85.77 EUR. In the past month the price increased by 8.9%. In the past year, price decreased by -37.18%.
ILU.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TN8.DE | THERMO FISHER SCIENTIFIC INC | 25.1 | 182.80B | ||
| DAP.DE | DANAHER CORP | 28.55 | 135.76B | ||
| LO3.DE | LONZA GROUP AG-REG | 37.29 | 43.89B | ||
| QTS.DE | IQVIA HOLDINGS INC | 18.94 | 31.81B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 60.06 | 20.46B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 60.4 | 20.58B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 52.37 | 17.88B | ||
| SRT.DE | SARTORIUS AG | 42.06 | 14.36B | ||
| ESF0.DE | EUROFINS SCIENTIFIC | 17.53 | 11.49B | ||
| ERF.PA | EUROFINS SCIENTIFIC | 17.11 | 11.22B | ||
| QIA.DE | QIAGEN N.V. | 20.72 | 9.08B | ||
| 1BRKR.MI | BRUKER CORP | 16.34 | 5.00B |
Related stock screener links
About ILU.DE
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Company Info
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA US
Employees: 8970
Phone: 18582024500
ILLUMINA INC / ILU.DE FAQ
What does ILLUMINA INC do?
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
What is the stock price of ILLUMINA INC today?
The current stock price of ILU.DE is 85.77 EUR. The price decreased by -1.55% in the last trading session.
Does ILLUMINA INC pay dividends?
ILU.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of ILU stock?
ILU.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How many employees does ILLUMINA INC have?
ILLUMINA INC (ILU.DE) currently has 8970 employees.
What is ILLUMINA INC worth?
ILLUMINA INC (ILU.DE) has a market capitalization of 13.18B EUR. This makes ILU.DE a Large Cap stock.
ILU.DE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to ILU.DE. When comparing the yearly performance of all stocks, ILU.DE is a bad performer in the overall market: 92.74% of all stocks are doing better.
ILU.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE. ILU.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
ILU.DE Financial Highlights
Over the last trailing twelve months ILU.DE reported a non-GAAP Earnings per Share(EPS) of 3.58. The EPS increased by 352.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 29.37% | ||
| ROA | 20.67% | ||
| ROE | 55.71% | ||
| Debt/Equity | 0.66 |
ILU.DE Forecast & Estimates
29 analysts have analysed ILU.DE and the average price target is 97.79 EUR. This implies a price increase of 14.02% is expected in the next year compared to the current price of 85.77.
For the next year, analysts expect an EPS growth of 87.51% and a revenue growth -1.43% for ILU.DE